ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial

[1]  Jonathan C. Cohen,et al.  Genetic Variation in ANGPTL4 Provides Insights into Protein Processing and Function , 2009, Journal of Biological Chemistry.

[2]  Eric Boerwinkle,et al.  Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. , 2008, The Journal of clinical investigation.

[3]  P. Talmud,et al.  ANGPTL4 E40K and T266M: Effects on Plasma Triglyceride and HDL Levels, Postprandial Responses, and CHD Risk , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[4]  A. Rudich,et al.  Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men , 2007, Annals of Internal Medicine.

[5]  G. Bray,et al.  Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes , 2007, Diabetes Care.

[6]  Eric Boerwinkle,et al.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL , 2007, Nature Genetics.

[7]  J. Danesh,et al.  Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies , 2007, Circulation.

[8]  Yi Wang,et al.  BMC Medical Genetics , 2007 .

[9]  George A. Bray,et al.  Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study , 2006, Diabetes & vascular disease research.

[10]  T. Olivecrona,et al.  Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue , 2006, Proceedings of the National Academy of Sciences.

[11]  David M Nathan,et al.  TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. , 2006, The New England journal of medicine.

[12]  W. Benzer,et al.  Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? , 2005, Diabetes care.

[13]  S. Kersten.  Regulation of lipid metabolism via angiopoietin-like proteins. , 2005, Biochemical Society transactions.

[14]  Guoqing Yang,et al.  Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4 Published, JLR Papers in Press, August 1, 2004. DOI 10.1194/jlr.M400138-JLR200 , 2004, Journal of Lipid Research.

[15]  F. Marchlinski,et al.  Right Bundle-Branch Block Ventricular Tachycardias: Septal Versus Lateral Ventricular Origin Based on Activation Time to the Right Ventricular Apex , 2004, Circulation.

[16]  M. Woodward,et al.  Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region , 2004, Circulation.

[17]  Karen C Johnson,et al.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. , 2003, Controlled clinical trials.

[18]  C. Ballantyne,et al.  Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. , 1999, Atherosclerosis.

[19]  Y. Deshaies,et al.  Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. , 1999, Diabetes.

[20]  H. Lithell,et al.  Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.